RDW: The blood marker nobody knows (that predicts mortality)

Every year you get blood work done. Your doctor scans the results, nods, says “everything looks good.” You file the paper in a drawer and forget about it.

If RDW is high while hemoglobin is still normal, the narrower guide to high RDW with normal hemoglobin explains why early iron, B12, folate, or inflammation patterns may matter.

But there’s a number on that page your doctor almost certainly never mentioned — yet it predicts all-cause mortality better than many specialized tests. It’s called RDW, and it’s already there, in your latest blood count.

In 2009, an article in the Cleveland Clinic Journal of Medicine called it one of the “three neglected numbers in the CBC” — parameters measured routinely but systematically ignored in clinical practice. Since then, over 50 studies have confirmed that RDW is an independent predictor of cardiovascular, cancer, and all-cause mortality.

The most absurd part? You already have it in your hands. No additional test needed. Just someone to explain what those numbers mean.

For a lab-report reference page with ranges, aliases, and SuperAge context, see the RDW biomarker guide.

What You’ll Learn:

• What is RDW and why is it in your blood count
• Normal values and how to interpret them
• The 14% rule: RDW and mortality
• Why RDW predicts aging
• High RDW: causes and clinical significance
• How to read RDW and MCV together
• 6 strategies to improve RDW
• How SuperAge integrates RDW in biological age calculation
• FAQ

---

What is RDW?

RDW stands for Red Cell Distribution Width. It measures how different your red blood cells are from each other in terms of size.

Quick definition: RDW is a blood count parameter that expresses the variability in red blood cell size. A low value means your red blood cells are uniform (good). A high value means there’s a lot of difference between the smallest and largest (potential problem).

How It’s Measured

RDW is calculated automatically by the hematology analyzer during a routine complete blood count (CBC). No additional test needed — it’s already included.

Two variants exist:

Variant	Formula	Primary Use
RDW-CV	(Standard deviation / MCV) × 100	Percentage — most used in labs
RDW-SD	Direct standard deviation in femtoliters (fL)	Absolute value — more sensitive to small variations

In practice, when people say “RDW” without specifying, they almost always mean RDW-CV.

What “Different” Red Blood Cells Mean

Your red blood cells are born in the bone marrow, live about 120 days, and are then eliminated by the spleen. In a healthy body, circulating red blood cells are all roughly the same size (about 6-8 micrometers in diameter).

When RDW is high, red blood cells of very different sizes circulate simultaneously — a condition called anisocytosis. This can happen because:

• The bone marrow produces abnormal red blood cells (nutritional deficiency, disease)
• Old red blood cells are destroyed too quickly (oxidative stress)
• There’s chronic inflammation altering production

---

Normal Values and How to Interpret Them

RDW-CV Reference Range

Classification	RDW-CV	Meaning
Low	< 11.5%	Rarely problematic
Normal	11.5-14.5%	Uniformly sized red blood cells
Mildly Elevated	14.5-16.0%	Possible nutritional deficiency or early inflammation
Elevated	16.0-20.0%	Significant — requires investigation
Very Elevated	> 20.0%	Active pathology likely

Note: Ranges may vary slightly between laboratories. Always refer to the reference values printed on your report.

“Normal” Range Isn’t the “Optimal” Range

Here’s a fundamental concept standard medicine often overlooks: being within the normal range doesn’t mean being in the optimal range for longevity.

A study of 15,852 adults from the NHANES III database showed that mortality begins to increase with RDW values above 13.0% — well within the “normal” range (Patel et al., 2009).

Range	Longevity Interpretation
< 12.5%	Optimal for longevity
12.5-13.5%	Good — monitor over time
13.5-14.5%	Caution — “normal” but not optimal
> 14.5%	Elevated — investigation needed

Translation: an RDW of 14.2% will be flagged as “within normal limits” on your report, but in terms of cardiovascular risk and mortality, it’s far from optimal.

---

The 14% Rule: RDW and Mortality

This is the part that should get your attention.

The Meta-Analysis That Changed Everything

In 2014, a meta-analysis published in PLOS ONE aggregated data from over 230,000 patients and found an impressive result:

Each 1% increase in RDW is associated with a 14% increase in all-cause mortality.

Not 14% total mortality. 14% more for each single percentage point. An RDW of 15% compared to 13% doesn’t mean a 14% risk increase — it means about 28% more (Patel et al., 2009).

The Numbers in Detail

Outcome	Risk Increase per +1% RDW	Source
All-cause mortality	+14%	Meta-analysis, 230,000+ subjects
Cardiovascular mortality	+15%	Felker et al., JACC 2007
Cancer mortality	+13%	Meta-analysis adults over 45
Major cardiovascular events (MACE)	+19%	Frontiers in Cardiovascular Medicine, 2023

Stronger Than Cholesterol?

To put things in perspective: elevated LDL cholesterol increases cardiovascular risk by about 20-30% overall. RDW, with an increase of just 2-3 percentage points above the optimal range, can reach comparable risk levels.

The difference? Everyone monitors cholesterol. Nobody looks at RDW.

It Works Even in Healthy People

A crucial aspect: RDW predicts mortality even in apparently healthy people, without anemia and without known chronic diseases. This is what makes it so powerful as a preventive biomarker — you don’t need to be sick for RDW to tell you something important.

---

Why RDW Predicts Aging

If RDW only measures red blood cell size, how can it predict mortality? The answer lies in the fact that RDW doesn’t measure just red blood cell size — it’s a window into deeper biological processes.

1. Oxidative Stress

Oxidative stress is one of the main drivers of cellular aging. When free radicals overwhelm the body’s antioxidant defenses, they damage cell membranes — including those of red blood cells.

A 2023 study published in Scientific Reports demonstrated in vitro and in silico that oxidative stress is the primary driver of RDW increase: free radicals damage erythrocyte membranes, reduce their survival, and cause anisocytosis (Gao et al., 2023).

Your RDW, in a sense, is an indirect measure of how much oxidative stress your body is experiencing — much like LDH (lactate dehydrogenase), another systemic marker of cell damage.

2. Chronic Inflammation

Low-grade chronic inflammation (inflammaging) is another pillar of biological aging. RDW is closely correlated with levels of:

• C-reactive protein (CRP) — classic inflammation marker
• Interleukin-6 (IL-6) — pro-inflammatory cytokine
• TNF-α — tumor necrosis factor

A study of 17,689 adults confirmed that low antioxidant levels (carotenoids, selenium) and high inflammation levels are the main predictors of elevated RDW (Lippi et al., 2011).

3. Bone Marrow Alterations

With age, bone marrow becomes less efficient. Red blood cell production (erythropoiesis) becomes irregular, generating cells of more variable sizes. RDW captures this productive “disorganization.”

4. Telomere Connection

A genetics study published in 2017 identified an association between elevated RDW and genetic variants involved in telomere maintenance, ribosomal RNA production, and apoptosis — all central processes in cellular aging (Pilling et al., 2017).

5. RDW in the PhenoAge Formula

It’s no coincidence that RDW is one of the 9 biomarkers used by PhenoAge — the algorithm developed by Morgan Levine at Yale to calculate biological age from blood tests. Among all blood count parameters, RDW was selected as the most informative for predicting mortality (Levine et al., 2018).

If you want to learn more about how PhenoAge works and how all 9 biomarkers work together, read our dedicated article: PhenoAge and KDM: How to Calculate Biological Age from Blood Tests.

6. The 2025–2026 evidence: RDW as a universal prognostic biomarker

The case for RDW as more than just a CBC footnote has only grown stronger. Three meta-analyses and one large mini-review published in 2025 have extended its reach into virtually every major clinical setting:

Clinical setting	2025 evidence	Effect size
Pediatric ICU (Frontiers in Pediatrics, 2025)	Meta-analysis of 7 studies, 6,327 children	Each unit increase in RDW: OR 1.24 (95% CI 1.07–1.44) for mortality
Heart failure (2025 meta-analysis)	Highest quartile (RDW > 15.21%)	OR 1.84 (95% CI 1.31–2.57) for all-cause mortality
Cardiovascular disease (RAR ratio) (2025 dose-response meta-analysis)	RDW-to-albumin ratio in CVD patients	HR 1.88 (95% CI 1.59–2.23) for mortality
Traumatic brain injury (2025 mediation analysis)	Q4 vs Q1 RDW in TBI patients	2.06× higher 28-day mortality risk
Systemic diseases (mini-review) (Springer, 2025)	Synthesis across infectious, autoimmune, cardiovascular, and oncologic disease	RDW emerges as a unifying signal of biological stress

The reason RDW works across such different diseases is the same reason it works for biological aging: it captures upstream biology — oxidative stress, inflammation, marrow function — that all serious illness eventually disturbs. A 2024 metabolomics study on inflammageing and frailty arrived at the same conclusion from a different direction: RDW correlates tightly with the metabolomic signatures of accelerated aging in older adults.

The longitudinal twist: A pattern emerging in 2025 research is that trajectory matters as much as the absolute value. Individuals whose RDW rises steeply over years carry higher mortality risk independent of the most recent reading — another argument for tracking RDW across annual blood panels rather than checking it once.

---

High RDW: Causes and Clinical Significance

An elevated RDW can have many causes. Here are the main ones, from most to least common.

Nutritional Causes (Most Common)

Deficiency	Mechanism	Effect on RDW
Iron	Bone marrow produces microcytes (small red blood cells)	RDW ↑ with MCV ↓
Vitamin B12	Ineffective erythropoiesis, macrocytes (large red blood cells)	RDW ↑ with MCV ↑
Folic Acid	Similar to B12, defect in DNA synthesis	RDW ↑ with MCV ↑

Inflammatory and Chronic Causes

• Low-grade chronic inflammation (inflammaging)
• Autoimmune diseases (rheumatoid arthritis, lupus)
• Chronic kidney disease
• Heart failure
• Chronic liver diseases

Less Common Causes

• Thalassemia and other hemoglobinopathies
• Myelodysplastic syndromes
• Recent chemotherapy
• Post-transfusion (mix of own and transfused red blood cells)

When to Worry

A mildly elevated RDW (14.5-16%) in an otherwise healthy person may indicate an easily correctable nutritional deficiency. A persistently elevated RDW (> 16%) that doesn’t respond to supplementation requires medical workup.

Important: RDW alone doesn’t diagnose. It must always be interpreted in the context of the complete blood count and clinical history.

---

How to Read RDW and MCV Together

RDW alone tells you something is wrong. Combined with MCV (Mean Corpuscular Volume), it tells you what is wrong.

The RDW × MCV Diagnostic Matrix

	Low MCV (< 80 fL)	Normal MCV (80-100 fL)	High MCV (> 100 fL)
Normal RDW	Thalassemia minor, chronic disease	Normal, chronic disease	Liver disease, aplastic anemia
High RDW	Iron deficiency, thalassemia S/β	Mixed deficiencies, sideroblastic	B12/folate deficiency, reticulocytosis

Practical Example

You have an RDW of 16.2% and MCV of 72 fL (low): → Highly suggestive of iron deficiency. Next step: check ferritin, serum iron, and transferrin saturation.

You have an RDW of 15.8% and MCV of 108 fL (high): → Compatible with vitamin B12 or folic acid deficiency. Next step: measure serum B12 and folate.

You have an RDW of 15.0% and MCV of 88 fL (normal): → Possible chronic inflammation or mixed nutritional deficiencies. Next step: check CRP, ferritin, B12.

---

6 Strategies to Improve RDW

RDW is modifiable. Since red blood cells have a lifespan of about 120 days, changes you make today will be reflected in values within 3-4 months. Here’s what science says.

1. Correct Nutritional Deficiencies

The most common cause of elevated RDW is iron, vitamin B12, or folic acid deficiency. Before any lifestyle intervention:

• Get ferritin, B12, and folate tested — don’t rely solely on the blood count
• Iron: Optimal ferritin range: 50-150 ng/mL (not just > 12 ng/mL)
• B12: Optimal range: > 500 pg/mL (not just > 200 pg/mL)
• Folate: Optimal range: > 10 ng/mL

Why it works: Restoring nutrients necessary for erythropoiesis allows the bone marrow to produce uniformly sized red blood cells.

2. Move Regularly

A 2015 study of American adults demonstrated that regular physical activity is associated with lower RDW levels, independent of other cardiovascular risk factors (Loprinzi, 2015).

How much: At least 150 minutes/week of moderate activity (brisk walking at 3.4 mph / 5.5 km/h) or 75 minutes/week of vigorous activity.

Why it works: Exercise reduces chronic oxidative stress, improves bone marrow function, and lowers inflammatory markers.

3. Optimize Antioxidants

The NHANES III study identified low levels of carotenoids and selenium as independent predictors of elevated RDW.

Key food sources:

• Carotenoids: Carrots, tomatoes, squash, spinach, sweet potatoes
• Selenium: Brazil nuts (1-2 per day = sufficient dose), fish, eggs
• Vitamin E: Almonds, sunflower seeds, avocado
• Vitamin C: Citrus fruits, kiwi, bell peppers (also enhances iron absorption)

Why it works: Antioxidants protect red blood cell membranes from oxidative stress, reducing premature destruction and anisocytosis.

4. Control Chronic Inflammation

If your RDW is elevated but you don’t have nutritional deficiencies, the culprit may be chronic inflammation. Anti-inflammatory strategies:

• Mediterranean diet — associated with lower CRP and IL-6 levels
• Omega-3 — 2-3 servings of fatty fish per week (salmon, mackerel, sardines) or EPA/DHA supplementation
• Reduce refined sugar — added sugar fuels systemic inflammation
• Adequate sleep — 7-8 hours/night; chronic sleep deprivation increases inflammatory markers

5. Maintain a Healthy Body Weight

Obesity is associated with chronic inflammation and elevated oxidative stress — both direct drivers of high RDW. Loss of visceral fat (around organs) is particularly effective in reducing inflammatory markers.

You don’t need to reach an “ideal” weight — even a 5-10% reduction in body weight in overweight individuals shows significant improvements in inflammatory biomarkers.

6. Review Medications With Your Doctor

Some medications can influence RDW:

• Metformin → may reduce B12 absorption over time
• Proton pump inhibitors (PPIs) → chronic use associated with iron and B12 deficiency
• Methotrexate → interferes with folate metabolism
• Chemotherapy drugs → direct effect on erythropoiesis

If you take one of these medications and your RDW is elevated, discuss it with your doctor — never discontinue medications on your own.

Timeline: Red blood cells live about 120 days. After correcting the cause of elevated RDW, wait at least 3-4 months before reassessing. Change is not immediate.

---

How SuperAge Integrates RDW in Biological Age Calculation

While manually monitoring RDW is possible, understanding what it means in the overall context of your health is the difficult part. This is where SuperAge comes in.

Automatic Blood Test Scanning

With the PDF scanning feature, SuperAge reads your blood count report and automatically extracts RDW along with 70+ other biomarkers. No manual entry, no transcription errors.

Integrated PhenoAge Calculation

RDW is one of the 9 biomarkers used by the PhenoAge formula. SuperAge integrates it with the other 8 parameters (albumin, creatinine, glucose, CRP, lymphocytes, MCV, alkaline phosphatase, white blood cells) to calculate your real biological age.

Trends Over Time

SuperAge tracks your RDW trend over time, allowing you to see if the strategies you’re adopting are working. Remember: it takes 3-4 months to see changes.

Apple Watch Data Integration

The unique added value: SuperAge combines your blood biomarkers (like RDW) with continuous Apple Watch data (HRV, VO2 Max, resting heart rate, sleep) for a complete picture of your biological aging — not just an isolated number, but an ecosystem of data.

---

Frequently Asked Questions

What is a Normal RDW?

The standard reference range for RDW-CV is 11.5-14.5%. However, longevity studies suggest that a value below 13% is associated with the lowest mortality risk.

Is a Low RDW a Problem?

No, a low RDW (< 11.5%) is rarely clinically significant. It simply indicates that your red blood cells are very uniform in size — generally a good sign.

Can RDW Really Predict How Long I’ll Live?

RDW doesn’t predict the date of death, but the statistical risk of mortality. A meta-analysis of over 230,000 people demonstrated that each 1% increase is associated with a 14% increase in all-cause mortality. It’s one of the most powerful biomarkers that exist for risk stratification.

How Long Does It Take to Improve RDW?

Given that red blood cells have a lifespan of about 120 days, changes are typically seen after 3-4 months from intervention. Don’t expect changes in the first weeks.

My Doctor Never Mentioned RDW. Why?

RDW has historically been used only as an auxiliary tool for anemia diagnosis. Its role as a mortality and aging predictor emerged in scientific research over the last 15 years, but hasn’t yet entered routine clinical practice. This Cleveland Clinic Journal article titled “Three neglected numbers in the CBC” explains exactly why.

What’s the Difference Between RDW-CV and RDW-SD?

RDW-CV is a percentage value (most used in Europe and the US). RDW-SD is an absolute value in femtoliters (fL), more sensitive to small variations in red blood cell distribution. Most laboratories report RDW-CV.

---

Key Takeaways

• RDW is already in your blood count — no additional test needed to know it
• Each +1% RDW = +14% mortality for all causes, according to a meta-analysis of 230,000+ people
• The “normal” range isn’t optimal — risk begins to increase above 13%, well before the 14.5% limit
• RDW reflects deep processes — oxidative stress, chronic inflammation, bone marrow efficiency, telomere health
• It’s one of 9 PhenoAge biomarkers — the reference algorithm for biological age
• It’s modifiable — nutrition, exercise, antioxidants, and inflammation control can improve it in 3-4 months
• Combine RDW and MCV to understand the cause: low iron, low B12, or inflammation

---

Start Monitoring Your RDW Today

RDW is probably the biomarker with the best “predictive power / attention it receives” ratio in the entire hematological panel. It’s there, in your last blood count, waiting to be read with fresh eyes.

Next time you get blood work done, don’t just look at cholesterol and glucose. Look for RDW. And if it’s above 13%, ask yourself why.

Want to transform your blood tests into an aging map? Download SuperAge and upload your report to discover your real biological age — RDW included.

---

References

1. Patel KV, Ferrucci L, Ershler WB, et al. “Red blood cell distribution width and the risk of death in middle-aged and older adults.” Archives of Internal Medicine, 2009. DOI: 10.1001/archinternmed.2009.93
2. Felker GM, Allen LA, Pocock SJ, et al. “Red cell distribution width as a novel prognostic marker in heart failure.” Journal of the American College of Cardiology, 2007. DOI: 10.1016/j.jacc.2007.02.067
3. Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. “Red blood cell distribution width: a simple parameter with multiple clinical applications.” Critical Reviews in Clinical Laboratory Sciences, 2015.
4. Pilling LC, Atkins JL, Kuchel GA, et al. “Red blood cell distribution width: Genetic evidence for aging pathways in 116,666 volunteers.” PLOS ONE, 2017. DOI: 10.1371/journal.pgen.1006972
5. Gao S, et al. “In-vitro and in-silico evidence for oxidative stress as drivers for RDW.” Scientific Reports, 2023. DOI: 10.1038/s41598-023-36514-5
6. Levine ME, et al. “An epigenetic biomarker of aging for lifespan and healthspan.” Aging, 2018. DOI: 10.18632/aging.101414
7. Loprinzi PD. “Physical activity and dietary behavior with red blood cell distribution width.” Preventive Medicine, 2015. DOI: 10.1016/j.ypmed.2015.06.014
8. Lippi G, Targher G, Montagnana M, et al. “Relation between red blood cell distribution width and inflammatory biomarkers.” Clinical Chimica Acta, 2009.
9. Patel HH, Patel HR, Higgins JM. “Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease.” American Journal of Hematology, 2015.
10. “Three neglected numbers in the CBC: The RDW, MPV, and NRBC count.” Cleveland Clinic Journal of Medicine, 2019. DOI: 10.3949/ccjm.86a.18072
11. Red blood cell distribution width as a predictor of mortality in critically ill pediatric patients: a systematic review and meta-analysis. Frontiers in Pediatrics, 2025. Full text — 7 studies, 6,327 children: OR 1.24 per unit RDW increase.
12. Red Cell Distribution Width as a Prognostic Marker in Systemic Diseases: A Mini Review. Indian Journal of Hematology and Blood Transfusion, 2025. DOI: 10.1007/s12288-025-02210-9 — Synthesis across infectious, autoimmune, cardiovascular, oncologic disease.
13. A systematic review and dose-response meta-analysis of red blood cell distribution width to albumin ratio as mortality predictor in cardiovascular disease. 2025. Full text — HR 1.88 for mortality in CVD patients with elevated RAR.
14. The red blood cell distribution width is associated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease. PLOS One, 2025. DOI: 10.1371/journal.pone.0321789 — RDW predicts mortality in NAFLD patients.

---

Last updated: 2026-06-17. This article is periodically reviewed for scientific accuracy. The information presented here is for educational purposes and does not replace medical advice.